Industry: Drug development for cancer and cancer-related side effects
QUE Oncology is developing novel therapies to treat cancer and alleviate cancer-related symptoms.
While great progress has been made in cancer treatment, many forms of cancer still lack effective treatments. Additionally, many existing treatments come with side effects that are intolerable for some patients.
QUE Oncology is pursuing treatments to fill these gaps. It has a growing portfolio of drug-based assets to treat cancer or negative effects associated with cancer treatment. QUE’s leading drug candidate, Q-122, may offer a non-hormonal way to treat hot flashes in women with breast cancer who are receiving anti-estrogen therapy.
The company was founded by researchers from Emory University and the University of Queensland’s research commercialization company, UniQuest.
Company website: Que Oncology